摘要:
The invention relates to a cosmetic composition comprising, in a cosmetically acceptable medium: (i) one or more cationic polymers, at least one cationic polymer being a dimethyldiallylammonium chloride homopolymer, (ii) two or more than two cationic surfactants, (iii) one or more polysaccharide thickeners, (iv) one or more polyols with a molecular weight of less than 1000.
摘要:
Use, for the cosmetic treatment of keratin fibres such as the hair, of at least one volatile linear alkane and at least one liquid fatty ester of C1-30 mono- or dicarboxylic acid and of a C1-30 monohydric alcohol in an anhydrous medium, in a weight ratio of volatile linear alkane(s) to liquid fatty ester(s) of less than 5. Anhydrous composition comprising: at least one volatile linear alkane, at least one liquid fatty ester of a C1-30 mono- or dicarboxylic acid and of a C1-30 monohydric alcohol in a weight ratio of volatile linear alkane(s) to liquid fatty ester(s) of less than 5, and at least one oil selected from vegetable oils and silicone oils.
摘要:
Composition containing, in a cosmetically acceptable medium, two or more volatile linear alkanes, and one or more nonprotein cationic polymers, with a volatile linear alkanes/polymer(s) ratio by weight of greater than or equal to 1.2. Use in the treatment of keratinous substances, preferably keratinous fibres, such as the hair.
摘要:
The invention relates to a composition, especially a cosmetic composition, comprising: (i) one or more alkoxysilanes, (ii) one or more fatty esters; and (iii) one or more silicones. The invention also relates to a cosmetic process for treating keratin materials with this composition, and also to the use of this composition for caring for and/or shaping keratin materials.
摘要:
The invention relates to compositions and their use for conditioning keratin fibres, in particular the hair. The composition contains in a cosmetically acceptable medium, one or more volatile linear alkanes, and one or more nonionic associative polymers.
摘要:
The invention relates to a composition, especially a cosmetic composition, comprising: (i) one or more alkoxysilanes, and (ii) one or more starches modified with an acid or an acid derivative. The invention also relates to a cosmetic process for treating keratin materials with this composition, and also to the use of this composition for caring for and/or shaping keratin materials.
摘要:
Use, for the cosmetic treatment of keratin fibers such as the hair, of at least one volatile linear alkane and at least one liquid fatty ester of C1-30 mono- or dicarboxylic acid and of a C1-30 monohydric alcohol in an anhydrous medium, in a weight ratio of volatile linear alkane(s) to liquid fatty ester(s) of less than 5. Anhydrous composition comprising: at least one volatile linear alkane, at least one liquid fatty ester of a C1-30 mono- or dicarboxylic acid and of a C1-30 monohydric alcohol in a weight ratio of volatile linear alkane(s) to liquid fatty ester(s) of less than 5, and at least one oil selected from vegetable oils and silicone oils.
摘要:
This invention is directed to phosphoroamidate and phosphorodiamidate derivatives including the compounds of formula (I) having the structure wherein U, V, W, Z, R1, X1, X2, and Y are defined herein. These compounds and pharmaceutical compositions containing these compounds are useful in the treatment of viral infections in mammals infected by a virus in the Flaviviridae family of viruses, in particular hepatitis C virus (HCV). The compounds of this invention may be prepared by various methods known in the art of organic chemistry in general and nucleoside and nucleotide analog synthesis in particular.
摘要:
Composition containing, in a cosmetically acceptable medium, two or more volatile linear alkanes, and one or more nonprotein cationic polymers, with a volatile linear alkanes/polymer(s) ratio by weight of greater than or equal to 1.2. Use in the treatment of keratinous substances, preferably keratinous fibres, such as the hair.
摘要:
This invention is directed to novel compounds of formula (I) having the structure (I) wherein U, V, W, Z, R1, X1, X2, and Y are defined herein. The compounds of formula (I) and pharmaceutical compositions containing these compounds are useful in the treatment of viral infections in mammals mediated, at least in part, by a virus in the Flaviviridae family of viruses, in particular hepatitis C virus (HCV).